Real-time US stock market capitalization analysis and size classification for appropriate risk assessment. We help you understand how company size impacts volatility and expected returns in different market conditions.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Price Action
KROS - Stock Analysis
3336 Comments
1560 Likes
1
Jeleesa
Legendary User
2 hours ago
I nodded while reading this, no idea why.
π 208
Reply
2
Allanie
Registered User
5 hours ago
Indices are slightly volatile, suggesting that market participants are weighing multiple factors simultaneously.
π 57
Reply
3
Cloree
Elite Member
1 day ago
Insightful perspective that is relevant across multiple markets.
π 173
Reply
4
Sabella
New Visitor
1 day ago
Who else is trying to keep up with this trend?
π 95
Reply
5
Debbey
Senior Contributor
2 days ago
That was so impressive, I need a fan. π¨
π 121
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.